Skip to search formSkip to main contentSkip to account menu

travoprost

Known as: 5-Heptenoic Acid, 7-((1R,2R,3R,5S)-3,5-dihydroxy-2-((1E,3R)-3-hydroxy-4-(3-(trifluoromethyl)phenoxy)-1-butenyl)cyclopentyl)-, 1-methylethyl Ester,(5Z)-, Travoprost [Chemical/Ingredient], Travoprostum 
A synthetic lipophilic isopropyl ester prodrug of the active compound travoprost free acid, a prostaglandin F2alpha analog with anti-glaucoma… 
National Institutes of Health

Related topics

Related topics

17 relations

Narrower (3)

AL-6221TravatanTravatan Z

Broader (1)

Antihypertensive Agents
Drug AllergyGlaucoma, Open-AngleIn BloodPregnancy

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2014
Highly Cited
2014
Emerging trabecular outflow drugs.
Glaucoma is a progressive optic neuropathy that is a leading cause of irreversible blindness worldwide.1 Elevated intraocular… 
2011
2011
Asymmetry of 24-hour intraocular pressure reduction by topical ocular hypotensive medications in fellow eyes.
2010
2010
Effects of repeated administrations of tafluprost, latanoprost, and travoprost on optic nerve head blood flow in conscious normal rabbits.
PURPOSE The aim of this study was to evaluate and compare the effects of repeated administrations of three prostaglandin F(2alpha… 
2010
2010
24-h Intraocular pressure control with evening-dosed travoprost/timolol, compared with latanoprost/timolol, fixed combinations in exfoliative glaucoma
PurposeTo evaluate 24-h efficacy of travoprost/timolol fixed combination (TTFC) vslatanoprost/timolol fixed combination (LTFC) in… 
2006
2006
Accuracy of an Electronic Monitoring and Reminder Device for Use With Travoprost Eye Drops
Purpose:To evaluate the accuracy of a prototype electronic device for recording eye drop usage. Participants and Methods:Ten… 
2006
2006
Cost-effectiveness of monotherapy treatment of glaucoma and ocular hypertension with the lipid class of medications.
2006
2006
Ocular hypotensive efficacy and safety of brinzolamide ophthalmic suspension 1% added to travoprost ophthalmic solution 0.004% therapy in patients with open-angle glaucoma or ocular hypertension*
ABSTRACT Objective: The primary objective of this study was to determine if combined travoprost ophthalmic solution 0.004% and… 
Highly Cited
2005
Highly Cited
2005
Prostaglandin analogues and mouse intraocular pressure: effects of tafluprost, latanoprost, travoprost, and unoprostone, considering 24-hour variation.
PURPOSE To establish a mouse model for the pharmacological analysis of antiglaucoma drugs, considering the effect of variations… 
2005
2005
Effects of Travoprost on Aqueous Humor Dynamics in Monkeys
Purpose:To determine the mechanism by which travoprost, a prodrug of a prostaglandin F2α analog, reduces intraocular pressure… 
2004
2004
Observed time between prescription refills for newer ocular hypotensive agents: the effect of bottle size.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)